High Myopia: Extended and Longterm Observation of Pathologic Myopia Patients With the Risk for Developing a Myopic Choroidal Neovascularization (CNV)
NCT03070717
·
clinicaltrials.gov ↗
COMPLETED
Status
153
Enrollment
INDUSTRY
Sponsor class
Conditions
Pathologic Myopia
Interventions
PROCEDURE:
Observation & Diagnosis
Sponsor
Novartis Pharmaceuticals